erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the...
the financial times and its journalism are subject to a self-regulation regime under the ft editorial code of practice:.
thanks for signing up as a global citizen. in order to create your account we need you to provide your email address. you can check out our